Identification of a novel immunodominant HLA-B∗07:02-restricted adenoviral peptide epitope and its potential in adoptive transfer Immunotherapy

Journal of Immunotherapy

Volumn 38, Issue 7, 2015, Pages 267-275

  Günther, Patrick S ^a   Peper, Janet K ^b   Faist, Benjamin ^a   Kayser, Simone ^c   Hartl, Lena ^c   Feuchtinger, Tobias ^c,d,e   Jahn, Gerhard ^a   Neuenhahn, Michael ^a,e   Busch, Dirk H ^a,e   Stevanović, Stefan ^b   Dennehy, Kevin M ^a,e  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e German Center of Infection Research   (Germany)

Author keywords

Adenovirus; Adoptive transfer immunotherapy; Cytotoxic T cell; Epitope; HLA

Indexed keywords

CD45RO ANTIGEN; EPITOPE; GAMMA INTERFERON; HLA ANTIGEN; HLA B ANTIGEN; CAPSID PROTEIN; HLA B7 ANTIGEN; HLA-B*07:02 ANTIGEN; PEPTIDE;

ADENOVIRUS INFECTION; ADOPTIVE TRANSFER; ARTICLE; CELL EXPANSION; CONTROLLED STUDY; ELUTION; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; TANDEM MASS SPECTROMETRY; VIRUS LOAD; ADENOVIRIDAE; ADOPTIVE IMMUNOTHERAPY; IMMUNOLOGY; PROCEDURES; TUMOR CELL LINE;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ADOPTIVE TRANSFER; CAPSID PROTEINS; CELL LINE, TUMOR; HLA-B7 ANTIGEN; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOTHERAPY, ADOPTIVE; PEPTIDES; T-LYMPHOCYTES;

EID: 84942745344     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/CJI.0000000000000087     Document Type: Article

References (16)

1. Feuchtinger T, Lang P, Handgretinger R. Adenovirus infection after allogeneic stem cell transplantation. Leuk Lymphoma. 2007;48:244-255.
2. Feuchtinger T, Matthes-Martin S, Richard C, et al. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol. 2006;134:64-76.
3. Feucht J, Opherk K, Lang P, et al. Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT. Blood. 2015;125:1986-1994.
4. Gerdemann U, Katari UL, Papadopoulou A, et al. Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant. Mol Ther. 2013;21:2113-2121.
5. Papadopoulou A, Gerdemann U, Katari UL, et al. Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. Sci Transl Med. 2014;6:242ra83.
6. Geyeregger R, Freimuller C, Stevanovic S, et al. Short-term invitro expansion improves monitoring and allows affordable generation of virus-specific T-cells against several viruses for a broad clinical application. PLoS One. 2013;8:e59592.
7. Leen AM, Sili U, Vanin EF, et al. Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. Blood. 2004;104:2432-2440.
8. Chakupurakal G, Onion D, Bonney S, et al. HLA-peptide multimer selection of adenovirus-specific T cells for adoptive T-cell therapy. J Immunother. 2013;36:423-431.
9. Fujisaki H, Kakuda H, Shimasaki N, et al. Expansion of highly cytotoxic human natural killer cells for cancer cell therapy. Cancer Res. 2009;69:4010-4017.
10. Greten TF, Korangy F, Neumann G, et al. Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes. J Immunol Methods. 2002;271:125-135.
11. Gunther PS, Mikeler E, Hamprecht K, et al. CD209/DC-SIGN mediates efficient infection of monocyte-derived dendritic cells by clinical adenovirus 2C isolates in the presence of bovine lactoferrin. J Gen Virol. 2011;92:1754-1759.
12. Kowalewski DJ, Stevanovic S. Biochemical large-scale identification of MHC class I ligands. Methods Mol Biol. 2013;960:145-157.
13. Schmitt A, Tonn T, Busch DH, et al. Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirusspecific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion. 2011;51:591-599.
14. Tang J, Olive M, Pulmanausahakul R, et al. Human CD8 + cytotoxic T cell responses to adenovirus capsid proteins. Virology. 2006;350:312-322.
15. Meyer VS, Kastenmuller W, Gasteiger G, et al. Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling. J Immunol. 2008;181:6371-6383.
16. Infantes S, Lorente E, Barnea E, et al. Multiple, nonconserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cells. Mol Cell Proteomics. 2010;9:1533-1539.